Cormorant Asset Management, LP Chemo Centryx, Inc. Call Options Transaction History

Cormorant Asset Management, LP

  • $1.43 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$46.35 - $61.69 $34.8 Million - $46.3 Million
-750,000 Reduced 75.0%
250,000 $13.7 Million
Q2 2020

Aug 14, 2020
BUY
$38.58 - $65.07 $14.5 Million - $24.4 Million
375,000 Added 60.0%
1,000,000 $57.5 Million
Q1 2020

May 15, 2020
BUY
$32.73 - $50.78 $12.3 Million - $19 Million
375,000 Added 150.0%
625,000 $25.1 Million
Q4 2019

Feb 14, 2020
BUY
$6.81 - $39.55 $1.7 Million - $9.89 Million
250,000 New
250,000 $9.89 Million

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email